Document Classification

Section Type: RESULTS

Text: However, co-administered neostigmine and dexmedetomidine significantly decreased scores at 24 and 72 h (Group C : 3. 0 [1. 0-5. 8] and 2. 0 [0. 3-3. 0] ; Group N : 1. 5 [0. 3-3. 4] and 0 [0-1. 3] ; Group D : 3. 5 [0-5. 0] and 0 [0-1. 4] ; and Group ND : 0 [0-1. 0] * and 0 [0-0] ; median [interquartile range] * P = 0. 0031, P = 0. 0045 compared with Group C).